The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
| Image |  |
|---|---|
| Description | scientific article published on 20 March 2017 |
| Author/s |
author: Anthony Wing-Hung Chan Myth T S Mok Alfred S. Cheng Yu Huang |
| Publication date | March 20, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |